닫기
18.97.14.88
18.97.14.88
close menu
제2형 당뇨병 환자의 약제치료 개정안 2017: 경구혈당강하제 단일요법
Focused Issue : Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association
이상열 ( Sang Youl Rhee )
UCI I410-ECN-0102-2018-500-004093549
* This article cannot be purchased.

When starting initial medication in people with type 2 diabetes mellitus (T2DM), the appropriate drug should be selected considering characteristics of the patient, efficacy, side effects, and cost. It is generally recommended to use metformin as the first-line treatment oral hypoglycemic agent in T2DM patients. Metformin is recommended as the first treatment because of its excellent glucose lowering effect, relatively mild side effects, long-term safety, low risk of hypoglycemia, and small weight gain. If it is difficult to use metformin as a first-line treatment, appropriate drugs can be selected based on the clinical situation.

[자료제공 : 네이버학술정보]
×